You are currently viewing Cancer Profiling Market to Witness 11.5% CAGR Boom Through 2024-30 – Latest MarkNtel Advisors Report

Cancer Profiling Market to Witness 11.5% CAGR Boom Through 2024-30 – Latest MarkNtel Advisors Report

  • Post author:
  • Post category:Business
  • Post comments:0 Comments

Market Overview: Global Cancer Profiling Market

According to MarkNtel Advisors, the Global Cancer Profiling Market By Type of Cancer (Breast Cancer, Colorectal Cancer, Gynecological Cancer, Leukemia, Prostate Cancer, Lung Cancer, Others), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays Analysis, Others), By Biomarker Type (Genomic Biomarkers, Proteomics Biomarkers, Others), By Cell Type (Germline, Somatic) and others and Region (2024-30). The comprehensive market analysis contains various aspects, including market size, regional market share, historical market trends, and future forecasts from 2024-30. The study outlines the prevailing drivers, restraints, unmet needs, and emerging trends within the market.

Global Cancer Profiling Market Insights: 2024-30

The Global Cancer Profiling Market size is estimated to grow at a CAGR of around 11.5% during the forecast period, i.e., 2024-30.

Request Sample Report – https://www.marknteladvisors.com/query/request-sample/cancer-profiling-market.html

Industry Opportunity:

Advancements in Bioinformatics Techniques to Improve Testing Outcome and Support Market Growth – In recent years, companies like Amazon, M2GEN, FOXO Technologies, etc., have been focussing on introducing their upgraded bioinformatics software and services, especially for the oncology market. These services are designed to provide fast, highly reliable, and secure software to process and analyze vast amounts of genomic, and proteomic data.

The introduction of advanced bioinformatics tools and services within the Global Cancer Profiling Market is enabling the expansion of cancer research and diagnostics services across various domains. Notably, companies have recently intensified their efforts in areas such as targeted therapies and drug discovery.

Global Cancer Profiling Market Segmentation:

The study conducts an in-depth analysis of existing designs and other fundamental features, estimating market size with a focus on value share, price, and production. The report also provides insights into application overviews based on consumption patterns. Leveraging Porter’s five forces analysis, the report offers predictive insights into how the industry is poised to evolve. The prominent segments in the market are,

-By Type of Cancer

  • Breast Cancer – Market Size & Forecast 2019-2030, USD Million
  • Colorectal Cancer – Market Size & Forecast 2019-2030, USD Million
  • Gynecological Cancer – Market Size & Forecast 2019-2030, USD Million
  • ‎Leukemia – Market Size & Forecast 2019-2030, USD Million
  • Prostate Cancer – Market Size & Forecast 2019-2030, USD Million
  • Lung Cancer – Market Size & Forecast 2019-2030, USD Million
  • Others (Pancreatic Cancer, Skin Cancer, etc.) – Market Size & Forecast 2019-2030, USD Million

-By Technology

  • Next-Generation Sequencing – Market Size & Forecast 2019-2030, USD Million
  • Polymerase Chain Reaction – Market Size & Forecast 2019-2030, USD Million
  • Mass Spectrometry – Market Size & Forecast 2019-2030, USD Million
  • In-Situ Hybridization – Market Size & Forecast 2019-2030, USD Million
  • Microarrays Analysis – Market Size & Forecast 2019-2030, USD Million
  • Others (Single-Cell Sequencing, etc.) – Market Size & Forecast 2019-2030, USD Million

-By Biomarker Type

  • Genomic Biomarkers- Market Size & Forecast 2019-2030, USD Million
  • Proteomics Biomarkers- Market Size & Forecast 2019-2030, USD Million
  • Others (Epigenetic Biomarkers, Metabolomics Biomarkers, etc.)- Market Size & Forecast 2019-2030, USD Million

-By Cell Type

  • Germline – Market Size & Forecast 2019-2030, USD Million
  • Somatic – Market Size & Forecast 2019-2030, USD Million

-By Application

  • Oncology Research – Market Size & Forecast 2019-2030, USD Million
  • Precision Medicine – Market Size & Forecast 2019-2030, USD Million
  • Clinical Diagnostics – Market Size & Forecast 2019-2030, USD Million
  • Others (Prognosis, Monitoring and Recurrence Detection, etc.) – Market Size & Forecast 2019-2030, USD Million

-By End-User

  • Hospitals and Clinics – Market Size & Forecast 2019-2030, USD Million
  • Research Institutions and Laboratories – Market Size & Forecast 2019-2030, USD Million
  • Diagnostic Service Providers – Market Size & Forecast 2019-2030, USD Million
  • Pharmaceutical and Biotechnology Companies – Market Size & Forecast 2019-2030, USD Million

-By Region

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia Pacific

Read Full Report -  https://www.marknteladvisors.com/research-library/cancer-profiling-market.html

Global Cancer Profiling Market Landscape for Competitors

A thorough examination of competitors is conducted, delving into market share, noteworthy developments, and crucial business strategies. Also, the research examines current breakthroughs, significant advancements, and pertinent details about start-ups in the industry. The report provides a rich repository of information on market entry strategies, the regulatory landscape, and reimbursement scenarios. The key players in the Cancer Profiling Market are

  • NeoGenomics Laboratories
  • Eurofins Genomics GmbH
  • Hoffmann-La Roche Ltd (Foundation Medicine)
  • OncoDNA SA
  • 10x Genomics, Inc.
  • Caris Life Sciences.
  • Geneseeq Technology Inc.
  • Genetron Holdings Limited
  • Laboratory Corporation of America Holdings (LabCorp)
  • Dante Labs Inc.
  • Celemics, Inc.
  • Strand Life Sciences
  • Myriad Genetics, Inc.
  • QIAGEN GmbH
  • Tempus Labs
  • Others

Request Customization – https://www.marknteladvisors.com/query/request-customization/cancer-profiling-market.html

Frequently Asked Questions Cancer Profiling Market

  1. What is the expected market share, CAGR, and Market valuation in USD for the forecast period, 2024-30?
  2. How do supply and consumption factors contribute to the Cancer Profiling Market landscape?
  3. How do import and export considerations impact the Cancer Profiling Industry?
  4. What obstacles do businesses encounter in the Cancer Profiling Market, and how can they leverage opportunities within it?
  5. What regulatory factors play a role in shaping the Cancer Profiling Market?
  6. In what ways has technology impacted the overall landscape of the Cancer Profiling Market?

More Reports:

About Us

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Media Representative

Company Name: MarkNtel Advisors

Email:sales@marknteladvisors.com

Phone: +1 628 895 8081, +91 120 4278433

Leave a Reply